Stéphanie Sarrazy Garcia

Stéphanie Sarrazy Garcia is an expert in skeletal dysplasia and in vivo experiments. She is experienced in the preclinical and pharmaceutical development of novel therapeutics for rare genetic conditions. Stéphanie previously worked as a Research Project Manager and Operation Manager at Therachon, where she supported the preclinical development of a therapeutic for achondroplasia. Prior to this, she was a post-doctoral fellow and Ph.D. student at INSERM. Stéphanie has multiple patents including one for the treatment of abnormal visceral fat deposition using soluble fibroblast growth factor receptors. She has also received the Cote D’Azur Innovation Award for best entrepreneurial engagement in the region. She holds a Ph.D. in biological sciences from the University of Paul Sabatier in Toulouse, France.